What are the Therapeutic Applications of Nanotechnology in CAD?
Nanotechnology has the potential to revolutionize the treatment of CAD by enabling targeted drug delivery and improving the efficacy of existing therapies. Nanocarriers such as liposomes and dendrimers can encapsulate therapeutic agents and deliver them directly to the site of atherosclerotic plaques, minimizing side effects and enhancing drug efficacy. Moreover, nanorobots could potentially perform precise surgical interventions at the nanoscale, removing or repairing damaged sections of the artery.
